[Vigabatrin in the treatment of epilepsy in patients with West syndrome and tuberous sclerosis].
To report the efficacy of vigabatrin in seizures control, as well as the electroencephalographic abnormalities in children with tuberous sclerosis and West syndrome. Retrospective study, with clinical, neuroimaging, and electroencephalographic data. Seven patients were followed, and the median time of follow-up was 10 years. Four of them were females and all were white. The mean age of seizures onset was 3.4 months. All patients used antiepileptic drugs associations, at least 2 drugs each therapeutic scheme, each one of the patients have used at least two different schemes. Vigabatrin as monotherapy or adjuvant was started in a mean age of seven years or 4 years after the onset of symptoms. Five from seven patients on vigabatrin became seizure free. Vigabatrin was efficient in seizures control, leading to a better prognosis.